Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Cirrhosis-Disease'

Cirrhosis-Disease published presentations and documents on DocSlides.

MM: HCV and Cirrhosis Patient Case
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Management of cirrhosis Dr
Management of cirrhosis Dr
by eliza
Nowlan Selvapatt. Consultant Hepatologist. Imperia...
LIVER CIRRHOSIS – AYURVEDIC
LIVER CIRRHOSIS – AYURVEDIC
by paisley
TREATMENT . Dr. . Vikram. . Chauhan. is One of ...
HBV related cirrhosis Geoff Dusheiko
HBV related cirrhosis Geoff Dusheiko
by maxasp
Kings College Hospital London UK. . 20–50%. . ...
Decompensated cirrhosis Clinical Practice Guidelines
Decompensated cirrhosis Clinical Practice Guidelines
by kittie-lecroy
About these slides. These slides give a comprehen...
Cirrhosis and complications
Cirrhosis and complications
by conchita-marotz
Best of ILC 2018. About these slides. These slide...
LIVER CIRRHOSIS –
LIVER CIRRHOSIS –
by danika-pritchard
AYURVEDIC . TREATMENT . Dr. . Vikram. . Chauhan....
Cirrhosis of the Liver
Cirrhosis of the Liver
by phoebe-click
Kelsey Conrad. Annelise. . Chmelik. September 24...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
by badra
Duke University School of Medicine. Durham, North ...
Translational Liver Consortia:
Translational Liver Consortia:
by susan2
TLC and THCCC. Hashem B. El-Serag, MD, MPH. Chair ...
Liver issues for the Rhuematologist
Liver issues for the Rhuematologist
by cappi
David Wong, MD. University of Toronto. www.toronto...
effusions
effusions
by trinity
leural occur in 5% to 10% of patients with cirrhos...
FROM CIRRHOSIS TO PARAPARESIS
FROM CIRRHOSIS TO PARAPARESIS
by morton
211 Corresponding author: PORTAbbreviationsCRP ...
archiv euromedica 31303130 29ol 2830 num
archiv euromedica 31303130 29ol 2830 num
by wilson
| archiv euromedica  ol...
COMPLICATIONS OF LIVER CIRRHOSIS
COMPLICATIONS OF LIVER CIRRHOSIS
by elyana
DR. SANJANA BHAGWAT. MODERATOR : DR. SHIMPA SHARMA...
Ascites and Hepatocellular carcinoma
Ascites and Hepatocellular carcinoma
by jocelyn
Curtis Barry, MD. UMASS ECHO. April 21, 2017. Asci...
Perazzo H et al
Perazzo H et al
by kylie
2017 16 2 269-278the DC the underlying cause was d...
HCV 2016 Alex Rodgers Hepatologist
HCV 2016 Alex Rodgers Hepatologist
by radions
. FMC. Disclosures. nil. Learning objectives/. t. ...
HEPATOBILIARY AND PANCREATIC DISORDERS
HEPATOBILIARY AND PANCREATIC DISORDERS
by enjoinsamsung
Dr. NADIA HAMEED. Bilirubin . Jundice. (Icterus)....
Management of Alcoholic Hepatitis
Management of Alcoholic Hepatitis
by friendma
and Cirrhosis. W. Ray Kim, MD. Gastroenterology an...
Mazen Hassanain Portal Hypertension
Mazen Hassanain Portal Hypertension
by escapistlego
Causes. Cirrhosis. Non-cirrhosis. Symptoms. Asympt...
INVESTOR FACT SHEET
INVESTOR FACT SHEET
by kittie-lecroy
INVESTOR FACT SHEET October 2011 Lipocine Inc. F...
Efficacy and Safety of
Efficacy and Safety of
by olivia-moreira
Efficacy and Safety of Glecaprevir / Pibrentasvi...
Alcoholic cirrhosis and acute alcoholic fatty liver with cholestasis
Alcoholic cirrhosis and acute alcoholic fatty liver with cholestasis
by karlyn-bohler
Case 3.13. 1. Chapter 3. Fatty Liver Diseases. Cl...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
Simplified HCV Therapy in 2018
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
Not randomised Open-label
Not randomised Open-label
by cheryl-pisano
18-70 years. HCV genotype 1 or 3. Naïve or failu...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by myesha-ticknor
in genotypes 1 or 3, with or without cirrhosis. &...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by pamella-moone
in genotypes 1 or 3, with or without cirrhosis. &...
No randomisation
No randomisation
by tatiana-dople
N = 100. W12. W24. Arm B: . compensated cirrhosis...
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
by pamella-moone
SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...
Cirrhosis prognostic quantification with ultrasound: an app
Cirrhosis prognostic quantification with ultrasound: an app
by briana-ranney
Ricardo Ribeiro. 1,2. , . Rui. . Tato. . Marinh...
Treatment regimens
Treatment regimens
by mitsue-stanley
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
What I need to know about Cirrhosis of the Liver NATIONAL INSTITUTES OF HEALTH National Digestive Diseases Information Clearinghouse Cirrhosis of the Liver U
What I need to know about Cirrhosis of the Liver NATIONAL INSTITUTES OF HEALTH National Digestive Diseases Information Clearinghouse Cirrhosis of the Liver U
by pasty-toler
S Department of Health and Human Services brPage 3...
Facts AtAGlance Cirrhosis is the scarring of the liver hard scar tissue replaces soft healthy tissue
Facts AtAGlance Cirrhosis is the scarring of the liver hard scar tissue replaces soft healthy tissue
by giovanna-bartolotta
Cirrhosis is caused by chronic longterm liver di...
Treatment regimens
Treatment regimens
by natalia-silvester
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
C-SALT Study:
C-SALT Study:
by marina-yarberry
grazoprevir. . + . elbasvir. . in genotype 1 wi...
Hepato renal syndrome Dr. S.
Hepato renal syndrome Dr. S.
by augustus
Parthasarathy. . MD., DA., DNB, Dip. . Diab. . DC...